E-ISSN 2146-9369 | ISSN 2146-3158
 
2024, Vol: 14, Issue: 4
14 / 4Current Issue ArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles

Review Article
Online Published: 27 Dec 2024


Middle East respiratory syndrome coronavirus (MERS-CoV): Virology, clinical features, epidemiology and prevention

Mariyam Luba Abdulla, Kannan Subbaram, Razana Faiz, Zeba Un Naher, Punya Laxmi Manandhar, Sheeza Ali, Sina Salajegheh Tazerji, Phelipe Magalhães Duarte.


Abstract
Middle East respiratory syndrome (MERS) is caused by the virus called, Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV belongs to the viral family of Coronaviridae of the genus beta Coronavirus. The aim of this article is to bring the recent developments on the virology, clinical features, epidemiology and prevention of MERS-CoV. Review of literature was conducted on MERS-CoV its past and present outbreaks, its relationship with SARS-CoV-2, virology, clinical features, complications, mortality rate, epidemiology, treatment and prevention. The literature search was performed between January 2010 to November 2024. The article listed in google scholar, Scopus, Web of Sciences, Embase, Hinari were used for this study. During this study we observed many interesting findings. This virus contains a single-stranded, non-segmented positive sense RNA genome of around 30 kb. Their morphological structures include a bi-layer lipoprotein envelope with glycoprotein spikes on the surface, surrounding the capsid containing the genome. It has several structural proteins, such as the protein envelope (E) protein and the spike (S) protein. This virus is genetically related to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) the causative agent of COVID-19. We would like to conclude that, MERS-CoV was identified in dromedary camels, and these camels acted as a source for transmission of the virus to humans as zoonosis. There were many cases of hospital (nosocomial) MERS outbreaks that have also been documented in Saudi Arabia. The clinical spectrum of MERS-CoV ranges from asymptomatic or mild respiratory illness to severe respiratory failure and multi-organ dysfunction. The case fatality rate of MERS-CoV was 36%, much higher than COVID-19. The future perspective of this study recommends that more detailed research to be carried out on molecular aspects, virulence, development of effective antiviral agents to counter MERS-CoV future outbreaks.

Key words: MERS-CoV, Dromedary camels, Mortality, Pathogenesis, Coronavirus


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Mariyam Luba Abdulla
Articles by Kannan Subbaram
Articles by Razana Faiz
Articles by Zeba Un Naher
Articles by Punya Laxmi Manandhar
Articles by Sheeza Ali
Articles by Sina Salajegheh Tazerji
Articles by Phelipe Magalhães Duarte
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Abdulla ML, Subbaram K, Faiz R, Naher ZU, Manandhar PL, Ali S, Tazerji SS, Duarte PM. Middle East respiratory syndrome coronavirus (MERS-CoV): Virology, clinical features, epidemiology and prevention. J Microbiol Infect Dis. 2024; 14(4): 158-164. doi:10.5455/JMID.20240828072847

Web Style

Abdulla ML, Subbaram K, Faiz R, Naher ZU, Manandhar PL, Ali S, Tazerji SS, Duarte PM. Middle East respiratory syndrome coronavirus (MERS-CoV): Virology, clinical features, epidemiology and prevention. https://www.jmidonline.org/?mno=217645 [Access: January 09, 2025]. doi:10.5455/JMID.20240828072847

AMA (American Medical Association) Style

Abdulla ML, Subbaram K, Faiz R, Naher ZU, Manandhar PL, Ali S, Tazerji SS, Duarte PM. Middle East respiratory syndrome coronavirus (MERS-CoV): Virology, clinical features, epidemiology and prevention. J Microbiol Infect Dis. 2024; 14(4): 158-164. doi:10.5455/JMID.20240828072847


Vancouver/ICMJE Style

Abdulla ML, Subbaram K, Faiz R, Naher ZU, Manandhar PL, Ali S, Tazerji SS, Duarte PM. Middle East respiratory syndrome coronavirus (MERS-CoV): Virology, clinical features, epidemiology and prevention. J Microbiol Infect Dis. (2024), [cited January 09, 2025]; 14(4): 158-164. doi:10.5455/JMID.20240828072847


Harvard Style

Abdulla, M. L., Subbaram, . K., Faiz, . R., Naher, . Z. U., Manandhar, . P. L., Ali, . S., Tazerji, . S. S. & Duarte, . P. M. (2024) Middle East respiratory syndrome coronavirus (MERS-CoV): Virology, clinical features, epidemiology and prevention. J Microbiol Infect Dis, 14 (4), 158-164. doi:10.5455/JMID.20240828072847


Turabian Style

Abdulla, Mariyam Luba, Kannan Subbaram, Razana Faiz, Zeba Un Naher, Punya Laxmi Manandhar, Sheeza Ali, Sina Salajegheh Tazerji, and Phelipe Magalhães Duarte. 2024. Middle East respiratory syndrome coronavirus (MERS-CoV): Virology, clinical features, epidemiology and prevention. Journal of Microbiology and Infectious Diseases, 14 (4), 158-164. doi:10.5455/JMID.20240828072847


Chicago Style

Abdulla, Mariyam Luba, Kannan Subbaram, Razana Faiz, Zeba Un Naher, Punya Laxmi Manandhar, Sheeza Ali, Sina Salajegheh Tazerji, and Phelipe Magalhães Duarte. "Middle East respiratory syndrome coronavirus (MERS-CoV): Virology, clinical features, epidemiology and prevention." Journal of Microbiology and Infectious Diseases 14 (2024), 158-164. doi:10.5455/JMID.20240828072847


MLA (The Modern Language Association) Style

Abdulla, Mariyam Luba, Kannan Subbaram, Razana Faiz, Zeba Un Naher, Punya Laxmi Manandhar, Sheeza Ali, Sina Salajegheh Tazerji, and Phelipe Magalhães Duarte. "Middle East respiratory syndrome coronavirus (MERS-CoV): Virology, clinical features, epidemiology and prevention." Journal of Microbiology and Infectious Diseases 14.4 (2024), 158-164. Print. doi:10.5455/JMID.20240828072847


APA (American Psychological Association) Style

Abdulla, M. L., Subbaram, . K., Faiz, . R., Naher, . Z. U., Manandhar, . P. L., Ali, . S., Tazerji, . S. S. & Duarte, . P. M. (2024) Middle East respiratory syndrome coronavirus (MERS-CoV): Virology, clinical features, epidemiology and prevention. Journal of Microbiology and Infectious Diseases, 14 (4), 158-164. doi:10.5455/JMID.20240828072847


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesPeer Review PolicyPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About Journal of Microbiology and Infectious Diseases

Journal of Microbiology and Infectious Diseases (JMID) is an international "peer review" journal in microbiology, infectious diseases, virology, ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information

All correspondence should be addressed to:

Prof. Ibrahim Eldaghayes

Editor-in-Chief

Journal of Microbiology and Infectious Diseases

Department of Microbiology and Parasitology 

Faculty of Veterinary Medicine

University of Tripoli

P.O. Box 13662, Tripoli, Libya